Late TNFα blockade is associated with systemic immune rewiring without disease control in established experimental autoimmune hepatitis
Open Access
- 25 August 2026
- journal article
- Published by Elsevier in Journal of Translational Autoimmunity
- Vol. 13
Abstract
No abstract availableFunding Information
- Deutsche Forschungsgemeinschaft (BU 2722 /2-3)
- Deutsche Forschungsgemeinschaft (HA 6880 /2-3)
This publication has 23 references indexed in Scilit:
- The Detrimental Role of Regulatory T Cells in Nonalcoholic SteatohepatitisHepatology Communications, 2021
- Treg-specific IL-2 therapy can reestablish intrahepatic immune regulation in autoimmune hepatitisJournal of Autoimmunity, 2021
- Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver DiseasesHepatology, 2019
- The influence of genetic predisposition and autoimmune hepatitis inducing antigens in disease developmentJournal of Autoimmunity, 2017
- Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine IntoleranceClinical Gastroenterology and Hepatology, 2016
- Risk of Drug-Induced Liver Injury From Tumor Necrosis Factor AntagonistsClinical Gastroenterology and Hepatology, 2015
- Diagnosis and Management of Autoimmune HepatitisClinics in Liver Disease, 2015
- Genetic Predisposition and Environmental Danger Signals Initiate Chronic Autoimmune Hepatitis Driven by CD4+ T CellsHepatology, 2013
- A Multifaceted Imbalance of T Cells with Regulatory Function Characterizes Type 1 Autoimmune Hepatitis†,‡Hepatology, 2010
- TNF‐mediated inflammatory diseaseThe Journal of Pathology, 2007